(4-Hexadecanoyl-3-hydroxy-5-oxo-2,5-dihydro-furan-2-yl)-acetic acid 4-benzoyl-phenyl ester

ID: ALA111092

Chembl Id: CHEMBL111092

Max Phase: Preclinical

Molecular Formula: C35H44O7

Molecular Weight: 576.73

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  CCCCCCCCCCCCCCCC(=O)C1=C(O)O[C@H](CC(=O)Oc2ccc(C(=O)c3ccccc3)cc2)C1=O

Standard InChI:  InChI=1S/C35H44O7/c1-2-3-4-5-6-7-8-9-10-11-12-13-17-20-29(36)32-34(39)30(42-35(32)40)25-31(37)41-28-23-21-27(22-24-28)33(38)26-18-15-14-16-19-26/h14-16,18-19,21-24,30,40H,2-13,17,20,25H2,1H3/t30-/m1/s1

Standard InChI Key:  QSRIHSVMAZGJRC-SSEXGKCCSA-N

Alternative Forms

  1. Parent:

    ALA111092

    ---

Associated Targets(Human)

DUSP3 Tchem Dual specificity protein phosphatase 3 (1161 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Cdc25b Dual specificity phosphatase Cdc25B (32 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 576.73Molecular Weight (Monoisotopic): 576.3087AlogP: 8.00#Rotatable Bonds: 20
Polar Surface Area: 106.97Molecular Species: ACIDHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 0.77CX Basic pKa: CX LogP: 9.95CX LogD: 6.32
Aromatic Rings: 2Heavy Atoms: 42QED Weighted: 0.06Np Likeness Score: 0.39

References

1. Sodeoka M, Sampe R, Kojima S, Baba Y, Usui T, Ueda K, Osada H..  (2001)  Synthesis of a tetronic acid library focused on inhibitors of tyrosine and dual-specificity protein phosphatases and its evaluation regarding VHR and cdc25B inhibition.,  44  (20): [PMID:11563920] [10.1021/jm0100741]

Source